<div style="max-width: 100%;"></div>
<p><script src="//players.brightcove.net/1571595826001/c0AOssA7_default/index.min.js">
</script></p>
<p>This morning the South African health minister Zweli Mkhize announced that it will be resuming its Johnson and Johnson vaccine rollout this week, through the department&#8217;s Sisonke Programme. This after the country halted the use of the vaccine due to concerns of blood clots after 6 cases in the US. The department says recent research shows that the cases of clotting are 1 in a million and that women between 18 and 48 are at particular risk. Koleka Mlisana, Co-chair of Covid-19 Ministerial Advisory Committee joins CNBC Africa for more.</p>


sisonke programme

SA’s J&J vaccine roll-out programme resumes

News Tips

Advertise With Us

sisonke programme

SA’s J&J vaccine roll-out programme resumes

News Tips

Advertise With Us

Newsletters